Skip to main content
Erschienen in: Metabolic Brain Disease 2/2020

01.02.2020 | Original Article

Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania

verfasst von: Samira Menegas, Gustavo C. Dal-Pont, José H. Cararo, Roger B. Varela, Jorge M. Aguiar-Geraldo, Taise Possamai-Della, Monica L. Andersen, João Quevedo, Samira S. Valvassori

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Evaluate the efficacy of folic acid (FA) as a therapeutic adjunct to lithium (Li) on the manic-like behaviors as well as parameters of oxidative stress and inflammation in an animal model of mania induced by m-amphetamine (m-AMPH). Wistar rats first received m-AMPH or saline (NaCl 0.9%, Sal) for 14 days. Between the 8th and 14th day, rats were treated with water, Li, FA or a combination of thereof drugs (Li + FA). Manic-like behaviors were assessed in the open-field test. Oxidative stress and inflammation parameters were assessed in the frontal cortex, striatum, and hippocampus. Administration of m-AMPH in rats significantly enhanced the exploratory and locomotor behaviors, as well as the risk-taking and stereotypic behaviors. Li + FA reversed these behavioral alterations elicited by m-AMPH. Administration of this psychostimulant also increased oxidative damage to lipids and proteins, whereas Li + FA reversed these oxidative damages. m-AMPH also induced an increase in the glutathione peroxidase (GPx) activity and a decrease in the glutathione reductase (GR) activity. Li + FA reversed the alteration in GR activity, but not in GPx activity. In addition, m-AMPH increased the IL-1β and TNF-α levels in the rat brain; Li + FA combined therapy reversed the alterations on these inflammatory parameters. FA administration per se reduced the increased TNF-α content induced by m-AMPH. Present study provides evidence that FA is effective as an adjunct to Li standard therapy on manic-like behaviors, oxidative stress and inflammatory parameters in a model of mania induced by m-AMPH.
Literatur
Zurück zum Zitat Abou-Saleh MT, Coppen AJ (1989) The efficacy of low-dose lithium: clinical, psychological and biological correlates. Psychiatry Res 23(2):157–162 Abou-Saleh MT, Coppen AJ (1989) The efficacy of low-dose lithium: clinical, psychological and biological correlates. Psychiatry Res 23(2):157–162
Zurück zum Zitat Ahmad S, Panda BP, Kohli K, Fahim M, Dubey K (2017) Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model. Pharm Biol 55(1):1295–1303PubMedPubMedCentral Ahmad S, Panda BP, Kohli K, Fahim M, Dubey K (2017) Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model. Pharm Biol 55(1):1295–1303PubMedPubMedCentral
Zurück zum Zitat Alda M (2015) Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry 20(6):661–670PubMedPubMedCentral Alda M (2015) Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry 20(6):661–670PubMedPubMedCentral
Zurück zum Zitat American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. 5. ed. American Psychiatric Publishing, Washington, D. C. 2013.xliv,847p American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. 5. ed. American Psychiatric Publishing, Washington, D. C. 2013.xliv,847p
Zurück zum Zitat Anderson G, Maes M (2015) Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep 17(2):8PubMed Anderson G, Maes M (2015) Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep 17(2):8PubMed
Zurück zum Zitat Baek JH, Bernstein EE, Nierenberg AA (2013) One-carbon metabolism and bipolar disorder. Aust N Z J Psychiatry 47(11):1013–1018PubMed Baek JH, Bernstein EE, Nierenberg AA (2013) One-carbon metabolism and bipolar disorder. Aust N Z J Psychiatry 47(11):1013–1018PubMed
Zurück zum Zitat Bedson E, Bell D, Carr D, Carter B, Hughes D, Jorgensen A, Lewis H, Lloyd K, McCaddon A, Moat S, Pink J, Pirmohamed M, Roberts S, Russell I, Sylvestre Y, Tranter R, Whitaker R, Wilkinson C, Williams N (2014) Folate Augmentation of Treatment--Evaluation for Depression (FolATED): randomised trial and economic evaluation. Health Technol Assess 18(48):vii-viii, 1–159 Bedson E, Bell D, Carr D, Carter B, Hughes D, Jorgensen A, Lewis H, Lloyd K, McCaddon A, Moat S, Pink J, Pirmohamed M, Roberts S, Russell I, Sylvestre Y, Tranter R, Whitaker R, Wilkinson C, Williams N (2014) Folate Augmentation of Treatment--Evaluation for Depression (FolATED): randomised trial and economic evaluation. Health Technol Assess 18(48):vii-viii, 1–159
Zurück zum Zitat Behzadi AH, Omrani Z, Chalian M, Asadi S, Ghadiri M (2009) Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. Acta Psychiatr Scand 120(6):441–445PubMed Behzadi AH, Omrani Z, Chalian M, Asadi S, Ghadiri M (2009) Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. Acta Psychiatr Scand 120(6):441–445PubMed
Zurück zum Zitat Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804–817PubMed Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804–817PubMed
Zurück zum Zitat Beyer DKE, Freund N (2017) Animal models for bipolar disorder: from bedside to the cage. Int J Bipolar Disord 5(1):35PubMedPubMedCentral Beyer DKE, Freund N (2017) Animal models for bipolar disorder: from bedside to the cage. Int J Bipolar Disord 5(1):35PubMedPubMedCentral
Zurück zum Zitat Broadhurst PL (1960) Experiments in psychogenetics: Application of biometrical genetics to the inheritance of behavior. In: Eisenk HJ (ed) Experiments in personality: Psychogenetics and psychopharmacology. Routledge & Kegan Paul, London, pp 31–71 Broadhurst PL (1960) Experiments in psychogenetics: Application of biometrical genetics to the inheritance of behavior. In: Eisenk HJ (ed) Experiments in personality: Psychogenetics and psychopharmacology. Routledge & Kegan Paul, London, pp 31–71
Zurück zum Zitat Brocardo PS, Budni J, Pavesi E, Franco JL, Uliano-Silva M, Trevisan R, Terenzi MG, Dafre AL, Rodrigues AL (2010) Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain. Bipolar Disord 12(4):414–424PubMed Brocardo PS, Budni J, Pavesi E, Franco JL, Uliano-Silva M, Trevisan R, Terenzi MG, Dafre AL, Rodrigues AL (2010) Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain. Bipolar Disord 12(4):414–424PubMed
Zurück zum Zitat Budni J, Freitas AE, Binfaré RW, Rodrigues AL (2012) Role of potassium channels in the antidepressant-like effect of folic acid in the forced swimming test in mice. Pharmacol Biochem Behav 101(1):148–154PubMed Budni J, Freitas AE, Binfaré RW, Rodrigues AL (2012) Role of potassium channels in the antidepressant-like effect of folic acid in the forced swimming test in mice. Pharmacol Biochem Behav 101(1):148–154PubMed
Zurück zum Zitat Coppen A, Abou-Saleh MT (1982) Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry 141:87–89PubMed Coppen A, Abou-Saleh MT (1982) Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry 141:87–89PubMed
Zurück zum Zitat Coppen A, Bolander-Gouaille C (2005) Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol 19:59–65PubMed Coppen A, Bolander-Gouaille C (2005) Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol 19:59–65PubMed
Zurück zum Zitat Coppen A, Chaudhry S, Swade C (1986) Folic acid enhances lithium prophylaxis. J Affect Disord 10(1):9–13PubMed Coppen A, Chaudhry S, Swade C (1986) Folic acid enhances lithium prophylaxis. J Affect Disord 10(1):9–13PubMed
Zurück zum Zitat da-Rosa DD, Valvassori SS, Steckert AV, Arent CO, Ferreira CL, Borges JL, Varela RB, Mariot E, Dal-Pizzol F, Andersen ML, Quevedo J (2012) Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats. J Neural Transm 119:31–38PubMed da-Rosa DD, Valvassori SS, Steckert AV, Arent CO, Ferreira CL, Borges JL, Varela RB, Mariot E, Dal-Pizzol F, Andersen ML, Quevedo J (2012) Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats. J Neural Transm 119:31–38PubMed
Zurück zum Zitat de Sousa RT, Zarate CA Jr, Zanetti MV, Costa AC, Talib LL, Gattaz WF, Machado-Vieira R (2014) Oxidative stress in early stage bipolar disorder and the association with response to lithium. J Psychiatr Res 50:36–41PubMed de Sousa RT, Zarate CA Jr, Zanetti MV, Costa AC, Talib LL, Gattaz WF, Machado-Vieira R (2014) Oxidative stress in early stage bipolar disorder and the association with response to lithium. J Psychiatr Res 50:36–41PubMed
Zurück zum Zitat Dhitavat S, Ortiz D, Rogers E, Rivera E, Shea TB (2005) Folate, vitamin E, and acetyl-L-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta. Brain Res 1061(2):114–117.PubMed Dhitavat S, Ortiz D, Rogers E, Rivera E, Shea TB (2005) Folate, vitamin E, and acetyl-L-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta. Brain Res 1061(2):114–117.PubMed
Zurück zum Zitat Djukic A (2007) Folate-responsive neurologic diseases. Pediatr Neurol 37(6):387–397PubMed Djukic A (2007) Folate-responsive neurologic diseases. Pediatr Neurol 37(6):387–397PubMed
Zurück zum Zitat Feier G, Valvassori SS, Lopes-Borges J, Varela RB, Bavaresco DV, Scaini G, Morais MO, Andersen ML, Streck EL, Quevedo J (2012) Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine. Neurosci Lett 530:75–79PubMed Feier G, Valvassori SS, Lopes-Borges J, Varela RB, Bavaresco DV, Scaini G, Morais MO, Andersen ML, Streck EL, Quevedo J (2012) Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine. Neurosci Lett 530:75–79PubMed
Zurück zum Zitat Feier G, Valvassori SS, Varela RB, Resende WR, Bavaresco DV, Morais MO, Scaini G, Andersen ML, Streck EL, Quevedo J (2013) Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine. Pharmacol Biochem Behav 103:89–96 Feier G, Valvassori SS, Varela RB, Resende WR, Bavaresco DV, Morais MO, Scaini G, Andersen ML, Streck EL, Quevedo J (2013) Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine. Pharmacol Biochem Behav 103:89–96
Zurück zum Zitat Frey BN, Martins MR, Petronilho FC, Dal-Pizzol F, Quevedo J, Kapczinski F (2006) Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord 8:275–280PubMed Frey BN, Martins MR, Petronilho FC, Dal-Pizzol F, Quevedo J, Kapczinski F (2006) Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord 8:275–280PubMed
Zurück zum Zitat Geddes JR, Gardiner A, Rendell J, Voysey M, Tunbridge E, Hinds C, Yu LM, Hainsworth J, Attenburrow MJ, Simon J, Goodwin GM, Harrison PJ (2016) Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial. Lancet Psychiatry 3(1):31–39PubMed Geddes JR, Gardiner A, Rendell J, Voysey M, Tunbridge E, Hinds C, Yu LM, Hainsworth J, Attenburrow MJ, Simon J, Goodwin GM, Harrison PJ (2016) Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial. Lancet Psychiatry 3(1):31–39PubMed
Zurück zum Zitat Ghanizadeh A, Singh AB, Berk M, Mv T-N (2015) Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies. Expert Opin Ther Targets 19(7):927–939PubMed Ghanizadeh A, Singh AB, Berk M, Mv T-N (2015) Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies. Expert Opin Ther Targets 19(7):927–939PubMed
Zurück zum Zitat Goncalves TM, Southey BR, Rodriguez-Zas SL (2018) Interplay between amphetamine and activity level in gene networks of the mouse striatum. Bioinform Biol Insights 12:1177932218815152PubMedPubMedCentral Goncalves TM, Southey BR, Rodriguez-Zas SL (2018) Interplay between amphetamine and activity level in gene networks of the mouse striatum. Bioinform Biol Insights 12:1177932218815152PubMedPubMedCentral
Zurück zum Zitat Grande I, Berk M, Birmaher B, Vieta E (2016) Bipolar disorder. Lancet 387(10027):1561–1572PubMed Grande I, Berk M, Birmaher B, Vieta E (2016) Bipolar disorder. Lancet 387(10027):1561–1572PubMed
Zurück zum Zitat Hasanah CI, Khan UA, Musalmah M, Razali SM (1997) Reduced red-cell folate in mania. J Affect Disord 46(2):95–99PubMed Hasanah CI, Khan UA, Musalmah M, Razali SM (1997) Reduced red-cell folate in mania. J Affect Disord 46(2):95–99PubMed
Zurück zum Zitat Keck PE Jr, Strakowski SM, Hawkins JM, Dunayevich E, Tugrul KC, Bennett JA, McElroy SL (2001) A pilot study of rapid lithium administration in the treatment of acute mania Bipolar Disord. Apr;3(2):68-72. Keck PE Jr, Strakowski SM, Hawkins JM, Dunayevich E, Tugrul KC, Bennett JA, McElroy SL (2001) A pilot study of rapid lithium administration in the treatment of acute mania Bipolar Disord. Apr;3(2):68-72. 
Zurück zum Zitat Kolling J, Scherer EB, da Cunha AA, da Cunha MJ, Wyse AT (2011) Homocysteine induces oxidative-nitrative stress in heart of rats: prevention by folic acid. Cardiovasc Toxicol 11(1):67–73PubMed Kolling J, Scherer EB, da Cunha AA, da Cunha MJ, Wyse AT (2011) Homocysteine induces oxidative-nitrative stress in heart of rats: prevention by folic acid. Cardiovasc Toxicol 11(1):67–73PubMed
Zurück zum Zitat Landersdorfer CB, Findling RL, Frazier JA, Kafantaris V, Kirkpatrick CM (2017) Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics. Clinical Pharmacokinetics 56 (1):77-90PubMed Landersdorfer CB, Findling RL, Frazier JA, Kafantaris V, Kirkpatrick CM (2017) Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics. Clinical Pharmacokinetics 56 (1):77-90PubMed
Zurück zum Zitat Li R, el-Mallakh RS, Harrison L, Changaris DG, Levy RS (1997) Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression. Mol Chem Neuropathol 31(1):65–72PubMed Li R, el-Mallakh RS, Harrison L, Changaris DG, Levy RS (1997) Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression. Mol Chem Neuropathol 31(1):65–72PubMed
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–267 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–267
Zurück zum Zitat Lucock M (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71(1–2):121–138PubMed Lucock M (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71(1–2):121–138PubMed
Zurück zum Zitat Machado-Vieira R, Zanetti MV, Otaduy MC, De Sousa RT, Soeiro-de-Souza MG, Costa AC, Carvalho AF, Leite CC, Busatto GF, Zarate CA Jr, Gattaz WF (2017) Increased brain lactate during depressive episodes and reversal effects by lithium monotherapy in drug-naive bipolar disorder: a 3-T 1H-MRS study. J Clin Psychopharmacol 37(1):40–45PubMedPubMedCentral Machado-Vieira R, Zanetti MV, Otaduy MC, De Sousa RT, Soeiro-de-Souza MG, Costa AC, Carvalho AF, Leite CC, Busatto GF, Zarate CA Jr, Gattaz WF (2017) Increased brain lactate during depressive episodes and reversal effects by lithium monotherapy in drug-naive bipolar disorder: a 3-T 1H-MRS study. J Clin Psychopharmacol 37(1):40–45PubMedPubMedCentral
Zurück zum Zitat Maes M, Landucci Bonifacio K, Morelli NR, Vargas HO, Barbosa DS, Carvalho AF, SOV N (2019) Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder. Mol Neurobiol 56(1):141–156PubMed Maes M, Landucci Bonifacio K, Morelli NR, Vargas HO, Barbosa DS, Carvalho AF, SOV N (2019) Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder. Mol Neurobiol 56(1):141–156PubMed
Zurück zum Zitat Mansouri-Guilani N, Bernardo V, Vigneault E, Vialou V, Daumas S, El Mestikawy S, Gangarossa G (2019) VGLUT3 gates psychomotor effects induced by amphetamine. J Neurochem 148(6):779–795PubMed Mansouri-Guilani N, Bernardo V, Vigneault E, Vialou V, Daumas S, El Mestikawy S, Gangarossa G (2019) VGLUT3 gates psychomotor effects induced by amphetamine. J Neurochem 148(6):779–795PubMed
Zurück zum Zitat Marx W, Moseley G, Berk M, Jacka F (2017) Nutritional psychiatry: the present state of the evidence. Proc Nutr Soc 76(4):427–436PubMed Marx W, Moseley G, Berk M, Jacka F (2017) Nutritional psychiatry: the present state of the evidence. Proc Nutr Soc 76(4):427–436PubMed
Zurück zum Zitat Matté C, Scherer EB, Stefanello FM, Barschak AG, Vargas CR, Netto CA, Wyse AT (2007) Concurrent folate treatment prevents Na+,K+-ATPase activity inhibition and memory impairments caused by chronic hyperhomocysteinemia during rat development. Int J Dev Neurosci 25(8):545–552PubMed Matté C, Scherer EB, Stefanello FM, Barschak AG, Vargas CR, Netto CA, Wyse AT (2007) Concurrent folate treatment prevents Na+,K+-ATPase activity inhibition and memory impairments caused by chronic hyperhomocysteinemia during rat development. Int J Dev Neurosci 25(8):545–552PubMed
Zurück zum Zitat Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26(3):137–146PubMed Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26(3):137–146PubMed
Zurück zum Zitat Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241–251PubMedPubMedCentral Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241–251PubMedPubMedCentral
Zurück zum Zitat Miller AL (2008) The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev 12(3):216–226 Miller AL (2008) The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev 12(3):216–226
Zurück zum Zitat Mitchell ES, Conus N, Kaput J (2014) B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline. Neurosci Biobehav Rev 47:307–320PubMed Mitchell ES, Conus N, Kaput J (2014) B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline. Neurosci Biobehav Rev 47:307–320PubMed
Zurück zum Zitat Nierenberg AA, Montana R, Kinrys G, Deckersbach T, Dufour S, Baek JH (2017) L-Methylfolate for bipolar I depressive episodes: an open trial proof-of-concept registry. J Affect Disord 207:429–433PubMed Nierenberg AA, Montana R, Kinrys G, Deckersbach T, Dufour S, Baek JH (2017) L-Methylfolate for bipolar I depressive episodes: an open trial proof-of-concept registry. J Affect Disord 207:429–433PubMed
Zurück zum Zitat Pereira C, Chavarria V, Vian J, Ashton MM, Berk M, Marx W, Dean OM (2018) Mitochondrial agents for bipolar disorder. Int J Neuropsychopharmacol 21(6):550–569PubMedPubMedCentral Pereira C, Chavarria V, Vian J, Ashton MM, Berk M, Marx W, Dean OM (2018) Mitochondrial agents for bipolar disorder. Int J Neuropsychopharmacol 21(6):550–569PubMedPubMedCentral
Zurück zum Zitat Rakofsky JJ, Dunlop BW (2014) Review of nutritional supplements for the treatment of bipolar depression. Depress Anxiety 31(5):379–390PubMed Rakofsky JJ, Dunlop BW (2014) Review of nutritional supplements for the treatment of bipolar depression. Depress Anxiety 31(5):379–390PubMed
Zurück zum Zitat Salagre E, Vizuete AF, Leite M, Brownstein DJ, McGuinness A, Jacka F, Dodd S, Stubbs B, Köhler CA, Vieta E, Carvalho AF, Berk M, Fernandes BS (2017) Homocysteine as a peripheral biomarker in bipolar disorder: a meta-analysis. Eur Psychiatry 43:81–91PubMed Salagre E, Vizuete AF, Leite M, Brownstein DJ, McGuinness A, Jacka F, Dodd S, Stubbs B, Köhler CA, Vieta E, Carvalho AF, Berk M, Fernandes BS (2017) Homocysteine as a peripheral biomarker in bipolar disorder: a meta-analysis. Eur Psychiatry 43:81–91PubMed
Zurück zum Zitat Sarris J (2017) Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders. Australas Psychiatry 25(4):369–372PubMed Sarris J (2017) Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders. Australas Psychiatry 25(4):369–372PubMed
Zurück zum Zitat Scaglione F, Panzavolta G (2014) Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica 44(5):480–488PubMed Scaglione F, Panzavolta G (2014) Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica 44(5):480–488PubMed
Zurück zum Zitat Segat HJ, Kronbauer M, Roversi K, Schuster AJ, Vey LT, Roversi K, Pase CS, Antoniazzi CT, Burger ME (2014) Exercise modifies amphetamine relapse: behavioral and oxidative markers in rats. Behav Brain Res 1(262):94–100 Segat HJ, Kronbauer M, Roversi K, Schuster AJ, Vey LT, Roversi K, Pase CS, Antoniazzi CT, Burger ME (2014) Exercise modifies amphetamine relapse: behavioral and oxidative markers in rats. Behav Brain Res 1(262):94–100
Zurück zum Zitat Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M, Geddes JR (2014) Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord 2:15PubMedPubMedCentral Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M, Geddes JR (2014) Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord 2:15PubMedPubMedCentral
Zurück zum Zitat Sharma AN, Fries GR, Galvez JF, Valvassori SS, Soares JC, Carvalho AF, Quevedo J (2016) Modeling mania in preclinical settings: a comprehensive review. Prog Neuro-Psychopharmacol Biol Psychiatry 3(66):22–34 Sharma AN, Fries GR, Galvez JF, Valvassori SS, Soares JC, Carvalho AF, Quevedo J (2016) Modeling mania in preclinical settings: a comprehensive review. Prog Neuro-Psychopharmacol Biol Psychiatry 3(66):22–34
Zurück zum Zitat Simon J, Geddes JR, Gardiner A, Rendell J, Goodwin GM, Mayer S (2018) Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL). Bipolar Disord 20(8):733–745PubMedPubMedCentral Simon J, Geddes JR, Gardiner A, Rendell J, Goodwin GM, Mayer S (2018) Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL). Bipolar Disord 20(8):733–745PubMedPubMedCentral
Zurück zum Zitat Singh R, Kanwar SS, Sood PK, Nehru B (2011) Beneficial effects of folic acid on enhancement of memory and antioxidant status in aged rat brain. Cell Mol Neurobiol 1;31(1):83–91PubMed Singh R, Kanwar SS, Sood PK, Nehru B (2011) Beneficial effects of folic acid on enhancement of memory and antioxidant status in aged rat brain. Cell Mol Neurobiol 1;31(1):83–91PubMed
Zurück zum Zitat Sylvia LG, Peters AT, Deckersbach T, Nierenberg AA (2013) Nutrient-based therapies for bipolar disorder: a systematic review. Psychother Psychosom 82(1):10–19PubMed Sylvia LG, Peters AT, Deckersbach T, Nierenberg AA (2013) Nutrient-based therapies for bipolar disorder: a systematic review. Psychother Psychosom 82(1):10–19PubMed
Zurück zum Zitat Tunbridge EM, Attenburrow MJ, Gardiner A, Rendell JM, Hinds C, Goodwin GM, Harrison PJ, Geddes JR (2017) Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: analysis of the CEQUEL clinical trial. Bipolar Disord 19(6):477–486PubMedPubMedCentral Tunbridge EM, Attenburrow MJ, Gardiner A, Rendell JM, Hinds C, Goodwin GM, Harrison PJ, Geddes JR (2017) Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: analysis of the CEQUEL clinical trial. Bipolar Disord 19(6):477–486PubMedPubMedCentral
Zurück zum Zitat Valvassori SS, Budni J, Varela RB, Quevedo J (2013) Contributions of animal models to the study of mood disorders. Rev Bras Psiquiatr 35(2):121–131 Valvassori SS, Budni J, Varela RB, Quevedo J (2013) Contributions of animal models to the study of mood disorders. Rev Bras Psiquiatr 35(2):121–131
Zurück zum Zitat Valvassori SS, Tonin PT, Varela RB, Carvalho AF, Mariot E, Amboni RT, Bianchini G, Andersen ML, Quevedo J (2015) Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine. Bipolar Disord 17(5):507–517PubMed Valvassori SS, Tonin PT, Varela RB, Carvalho AF, Mariot E, Amboni RT, Bianchini G, Andersen ML, Quevedo J (2015) Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine. Bipolar Disord 17(5):507–517PubMed
Zurück zum Zitat Valvassori SS, Dal-Pont GC, Resende WR, Varela RB, Lopes-Borges J, Cararo JH, Quevedo J (2019b) Validation of the animal model of bipolar disorder induced by Ouabain: face, construct and predictive perspectives. Transl Psychiatry 9(1):158PubMedPubMedCentral Valvassori SS, Dal-Pont GC, Resende WR, Varela RB, Lopes-Borges J, Cararo JH, Quevedo J (2019b) Validation of the animal model of bipolar disorder induced by Ouabain: face, construct and predictive perspectives. Transl Psychiatry 9(1):158PubMedPubMedCentral
Zurück zum Zitat Valvassori SS, Dal-Pont GC, Tonin PT, Varela RB, Ferreira CL, Gava FF, Andersen ML, Soares JC, Quevedo J (2019a) Coadministration of lithium and celecoxib attenuates the behavioral alterations and inflammatory processes induced by amphetamine in an animal model of mania. Pharmacol Biochem Behav 183:56–63PubMed Valvassori SS, Dal-Pont GC, Tonin PT, Varela RB, Ferreira CL, Gava FF, Andersen ML, Soares JC, Quevedo J (2019a) Coadministration of lithium and celecoxib attenuates the behavioral alterations and inflammatory processes induced by amphetamine in an animal model of mania. Pharmacol Biochem Behav 183:56–63PubMed
Metadaten
Titel
Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania
verfasst von
Samira Menegas
Gustavo C. Dal-Pont
José H. Cararo
Roger B. Varela
Jorge M. Aguiar-Geraldo
Taise Possamai-Della
Monica L. Andersen
João Quevedo
Samira S. Valvassori
Publikationsdatum
01.02.2020
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 2/2020
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-019-00503-3

Weitere Artikel der Ausgabe 2/2020

Metabolic Brain Disease 2/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.